Patents by Inventor Byoung Whui Choi

Byoung Whui Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma
    Patent number: 9078912
    Abstract: The present invention relates to a kit for the diagnosis or screening of asthma comprising neuropilin (NRP) gene, and to a method for screening a therapeutic agent for asthma using the same. More precisely, the present invention confirmed that NRP1 expression was increased in asthma patients and by D. pteronissinus extract. Based on the confirmation, the inventors confirmed that NRP1 could be effectively used as a target for the development of a therapeutic agent for asthma since the suppression of NRP1 expression resulted in the decrease of mRNA, protein, enzyme activity, and promoter activity of MMP-9 in relation to asthma.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: July 14, 2015
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyeong Kyu Lee, Kyung Seop Ahn, Yoosik Yoon, Byoung Whui Choi, Ok-Kyoung Kwon, Semi Kim, Hui Seong Kim, Sei Ryang Oh, Ji Eun Yuk, Ha Young Jang
  • ASTHMA DIAGNOSIS USING THE NEUROPILIN-1 GENE, AND METHOD FOR SCREENING FOR A THERAPEUTIC AGENT FOR ASTHMA
    Publication number: 20130108652
    Abstract: The present invention relates to a kit for the diagnosis or screening of asthma comprising neuropilin (NRP) gene, and to a method for screening a therapeutic agent for asthma using the same. More precisely, the present invention confirmed that NRP1 expression was increased in asthma patients and by D. pteronissinus extract. Based on the confirmation, the inventors confirmed that NRP1 could be effectively used as a target for the development of a therapeutic agent for asthma since the suppression of NRP1 expression resulted in the decrease of mRNA, protein, enzyme activity, and promoter activity of MMP-9 in relation to asthma.
    Type: Application
    Filed: July 1, 2011
    Publication date: May 2, 2013
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Hyeong Kyu Lee, Kyung Seop Ahn, Yoosik Yoon, Byoung Whui Choi, Ok-Kyoung Kwon, Semi Kim, Hui Seong Kim, Sei Ryang Oh, Ji Eun Yuk, Ha Young Jang